BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17070358)

  • 1. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy.
    Sengupta S; Davis BJ; Mynderse LA; Sebo TJ; Cheville JC; Lohse CM; Hillman DW; Haddock MG; Wilson TM
    Urology; 2006 Oct; 68(4):810-4. PubMed ID: 17070358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy.
    Davis BJ; Pisansky TM; Wilson TM; Rothenberg HJ; Pacelli A; Hillman DW; Sargent DJ; Bostwick DG
    Cancer; 1999 Jun; 85(12):2630-7. PubMed ID: 10375112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
    BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of prostate cancer pathologic features in Chinese populations.
    Chuang AY; Chang SJ; Horng CF; Tsou MH
    Urology; 2007 May; 69(5):915-20. PubMed ID: 17482934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer.
    Suardi N; Briganti A; Gallina A; Salonia A; Karakiewicz PI; Capitanio U; Freschi M; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2010 Jun; 105(11):1548-52. PubMed ID: 19912205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy after previous prostate surgery: effects on surgical difficulty and pathologic outcomes.
    Yazici S; Inci K; Yuksel S; Bilen CY; Ozen H
    Urology; 2009 Apr; 73(4):856-9. PubMed ID: 19022487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion].
    Losa CA; Fernando AB; Lázaro VA; Berlanga FF; Frago PS; López MA; Sanz MJ; Martínez PG; Sanz LA
    Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer.
    Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Lief JH; Adamovich E
    Am J Clin Oncol; 2008 Dec; 31(6):539-44. PubMed ID: 19060584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy.
    Wagner TT; Young D; Bahnson RR
    J Urol; 1999 Apr; 161(4):1216-8. PubMed ID: 10081872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical retropubic prostatectomy in Hispanic patients.
    Gomez P; Manoharan M; Sved P; Kim SS; Soloway MS
    Cancer; 2004 Apr; 100(8):1628-32. PubMed ID: 15073849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
    McAleese J; O'Sullivan JM
    Radiother Oncol; 2005 Apr; 75(1):121. PubMed ID: 15878111
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-benefit and outcome analysis: effect of prostate biopsy undergrading.
    Cambio AJ; Ellison LM; Chamie K; deVere White RW; Evans CP
    Urology; 2007 Jun; 69(6):1152-6. PubMed ID: 17572205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
    Guzzo TJ; Levin BM; Lee R; Guo M; Chen Z; Whittington R; Tomaszewski J; Malkowicz SB
    Urology; 2008 Apr; 71(4):723-7. PubMed ID: 18387401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.